CategoryScience & Research
5th International Conference of Multidisciplinary & Interdisciplinary Bioscience (MIBIO 2026)
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 5th International Conference of Multidisciplinary & Interdisciplinary Bioscience (MIBIO 2026) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
5th International Conference of Multidisciplinary & Interdisciplinary Bioscience (MIBIO 2026)
Date: July 28–29, 2026
Venue: Virtual Conference (Global Accessibility)
Event Type: Academic & Research-Focused Conference
Estimated Attendance: Not explicitly stated; typical virtual conferences of this nature range between 500–2,000 participants globally.
1️⃣ Who Attends (Buyers / Attendees)
MIBIO 2026 attracts a highly specialized audience centered around biological sciences and interdisciplinary research. Key attendee categories include:
- Research scientists and principal investigators
- Academicians (professors, lecturers, department heads)
- Biotechnology and pharmaceutical industry professionals
- Healthcare researchers and clinical scientists
- Graduate students and early-career researchers
- Representatives from government and non-profit research funding bodies
- Technology providers (e.g., genomics tools, bioinformatics software, lab equipment)
Buyer Profiles: Decision-makers in research institutions, university labs, biotech firms, and healthcare organizations seeking collaborations, emerging technologies, or talent acquisition.
2️⃣ Location + Attendee Geographic Origin
Show Location: Virtual (Online Platform)
Attendee Origin: Global. The virtual format enables participation from all regions, with an emphasis on:
- North America (academic and biotech hubs)
- Europe (research institutions and EU-funded projects)
- Asia-Pacific (rapidly growing biotech and genomics sectors)
- Emerging markets in Africa and South America (via international collaborations)
3️⃣ Audience Reach
Reach Type: Global. The conference explicitly aims to ensure "research reaches a broad international audience," supported by its virtual accessibility and focus on cutting-edge biological sciences.
4️⃣ Sample Buyer Company Names + Websites
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | thermofisher.com | Director of Research Collaborations | Global leader in life sciences instrumentation and reagents; active in genomics and proteomics. |
| 2 | CRISPR Therapeutics | crisprtherapeutics.com | Head of Gene Editing Research | Focus on CRISPR-based therapies; aligns with MIBIO’s genome editing and synthetic biology tracks. |
| 3 | Roche Diagnostics | roche.com | Senior Scientist, Molecular Biology | Major player in diagnostic and research tools for molecular and cellular biology. |
| 4 | Broad Institute of MIT and Harvard | broadinstitute.org | Principal Investigator, Genomics | Prominent research institute in genomics and biomedical innovation. |
| 5 | Stanford University - Department of Biology | stanford.edu | Chair, Department of Biology | Academic hub for interdisciplinary bioscience research and talent development. |
| 6 | Moderna | modernatx.com | VP, mRNA Technology Development | Leader in mRNA therapeutics; relevant to RNA biology and editing focus areas. |
| 7 | University of Tokyo - Institute for Genomic Sciences | genome.u-tokyo.ac.jp | Director, Genomic Research | Key Asian institution in genomics and computational biology. |
| 8 | Qiagen | qiagen.com | Senior Marketing Manager, Research Products | Provider of bioinformatics and lab solutions for molecular biology research. |
| 9 | Genentech | genentech.com | Research Scientist, Protein Engineering | Biotech leader in protein therapies and structural biology. |
| 10 | Harvard University - Wyss Institute | wyss.harvard.edu | Principal Investigator, Synthetic Biology | Renowned for interdisciplinary research in biomanufacturing and bioengineering. |
| 11 | European Bioinformatics Institute (EMBL-EBI) | ebi.ac.uk | Head of Computational Biology | Global leader in bioinformatics and multi-omics data analysis. |
| 12 | Regeneron Pharmaceuticals | regeneron.com | Director, Molecular Genetics | Focus on antibody discovery and genetic research. |
| 13 | University of Cambridge - Department of Biology | biol.cam.ac.uk | Professor of Cell Biology | Prestigious academic institution with strong cell and developmental biology programs. |
| 14 | Beam Therapeutics | beamtx.com | Chief Scientific Officer | Pioneer in base and prime editing technologies. |
| 15 | Max Planck Institute for Molecular Genetics | mpi-juelich.mpg.de | Department Director, Genomics | Leading European research institute in molecular biology and genomics. |
| 16 | University of California, San Francisco (UCSF) | ucsf.edu | Chair, Department of Biochemistry | Top-tier academic medical center with robust bioscience research programs. |
| 17 | Novartis Institutes for BioMedical Research | novartis.com | Head of Translational Research | Pharmaceutical leader integrating genomics and AI-driven drug discovery. |
| 18 | Allen Institute for Artificial Intelligence | allenai.org | Research Scientist, AI-Native Biology | Focus on AI applications in biological discovery and foundation models. |
| 19 | Oxford Nanopore Technologies | oxfordnanopore.com | Senior Product Manager, Genomic Sequencing | Leader in long-read sequencing technologies for genomics research. |
| 20 | MIT Media Lab | media.mit.edu | Research Scientist, Synthetic Biology | Interdisciplinary hub for innovation in biotechnology and digital fabrication. |
5️⃣ Job Profiles, Industries & Event Type
Best Job Profiles to Target:
- Principal Investigators
- Research Scientists (Genomics, Proteomics, SynBio)
- Academic Department Chairs
- Biotech R&D Managers
- Pharmaceutical Scientists
- Computational Biologists
- Director of Collaborations / Partnerships
- Chief Scientific Officers
Relevant Industries:
- Biotechnology
- Pharmaceuticals
- Academic Research
- Healthcare & Medical Devices
- Computer Software (Bioinformatics, AI-Native Biology)
- Genomics & Sequencing Services
- Synthetic Biology & Bioengineering
Event Type: Academic conference with a focus on research presentations, interdisciplinary collaboration, and technology showcase.
6️⃣ Estimated Attendance
While exact figures are not provided, virtual conferences of comparable scope (e.g., international interdisciplinary bioscience events) typically attract 500–2,000 participants. This includes researchers, students, industry professionals, and academics.
7️⃣ Key Focus Areas & Buyer Engagement
Key Focus Areas:
- Genomics & Genome Editing (CRISPR, Base Editing)
- Synthetic Biology & Biomanufacturing
- RNA Biology & Therapeutics
- Computational Biology & AI-Native Discovery
- Microbiology & Infectious Disease
- Protein Engineering & Structural Biology
Buyer Engagement Angle: Position as a platform to connect with decision-makers in research funding, biotech innovation, and academic collaboration. Highlight opportunities for partnerships in cutting-edge technologies (e.g., CRISPR, AI-driven drug discovery) and talent recruitment in biosciences.
8️⃣ Client-Product Fit Note
Please share your client’s website to refine targeting. For example:
- If your client sells gene-editing tools: Prioritize CRISPR Therapeutics, Beam Therapeutics, and academic labs focused on genome engineering.
- If your client provides bioinformatics software: Target EMBL-EBI, Allen Institute for AI, and computational biology teams at universities.
- If your client is in biomanufacturing: Focus on Harvard’s Wyss Institute, MIT Media Lab, and industry leaders like Thermo Fisher Scientific.
9️⃣ Final Recommendation
Quality Rating for B2B Engagement: 9/10
MIBIO 2026 offers high-value access to global bioscience leaders, particularly in genomics, synthetic biology, and AI-driven research. The virtual format enhances accessibility but may require targeted outreach to convert academic attendees into actionable B2B opportunities. Prioritize buyers from biotech firms, pharmaceutical companies, and research institutions with industrial collaboration mandates.
Data sheet
5th International Conference of Multidisciplinary & Interdisciplinary Bioscience (MIBIO 2026) – Event Attendee & Buyer Profile Analysis
Event date: July 28–29, 2026
Location: Virtual Conference
Event status: Upcoming
Research date: June 30, 2026
Event Overview
| Event Name | 5th International Conference of Multidisciplinary & Interdisciplinary Bioscience (MIBIO 2026) |
| Event Date | July 28–29, 2026 |
| Event Status | Upcoming |
| Venue | Virtual Conference |
| City | Virtual Conference |
| State / Region | Not publicly specified in the provided official source |
| Country | Virtual Conference |
| Organizer | NLAICSE branding appears on the official event website; organizer details are not otherwise fully specified in the provided source |
| Official Event Website | mibio2026.org |
| Event Type | Academic & Research-Focused Virtual Conference |
| Primary Category | Science & Research |
| Secondary Applicable Categories | Medical & Pharma; IT & Technology |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for attendance volume; no official participant count was identified in the provided official source |
| Main Purpose of Event | To provide an international peer-reviewed forum for researchers, scientists, physicians, academicians, and students to share multidisciplinary and interdisciplinary bioscience research, methods, and applications. |
About the Event
MIBIO 2026 is a virtual international conference positioned as a multidisciplinary and interdisciplinary bioscience forum. According to the official event website, the conference is designed for researchers, biologists, scientists, physicians, academicians, and students, with topic coverage spanning molecular biology, genomics, CRISPR, multiomics, microbiome science, computational biology, AI-native biology, synthetic biology, RNA therapeutics, biomanufacturing, and infectious disease biology.
From a business development perspective, the event matters because it brings together research-side and innovation-side participants who influence scientific tool adoption, collaborative research partnerships, publication visibility, translational science programs, data platforms, and laboratory technology evaluation. It is more relevant for academic, R&D, biotech, bioinformatics, instrumentation, and scientific software outreach than for high-volume procurement list building, because the provided official source does not disclose a buyer directory, exhibitor list, sponsor roster, or attendance volume.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Principal investigators and research scientists | Universities, research institutes, translational science centers, biotech R&D teams | High technical influence over lab platforms, assays, analytical tools, software, and collaborative projects | Core target for scientific instruments, bioinformatics, sequencing workflows, reagents, and publication or collaboration services |
| Academicians, professors, and department leaders | Academic departments, life science faculties, medical schools | Influence budget allocation, lab adoption, curriculum-linked tools, and research partnerships | Relevant for equipment vendors, research software, publishers, CRO partners, and grant-support services |
| Physicians and clinical researchers | Hospitals, academic medical centers, translational medicine programs | Evaluate translational applications, biomarker tools, RNA therapeutics relevance, and clinical research collaboration | Important for clinical research technology, molecular diagnostics support, and translational partnership outreach |
| Biotech and pharmaceutical R&D professionals | Biotechnology companies, pharmaceutical discovery teams, synthetic biology ventures | Can influence vendor selection for discovery workflows, omics platforms, AI models, and outsourced research support | Strong fit for platform providers, CROs, software vendors, and biomanufacturing technology suppliers |
| Bioinformatics, computational biology, and AI-driven bioscience teams | Research labs, AI-biology startups, biotech data science groups, academic computing programs | Influence software evaluation, cloud workflows, omics analytics, simulation, and ML tooling | High-value target for data infrastructure, AI platforms, modeling tools, and scientific computing services |
| Graduate students and early-career researchers | Universities and research training programs | Lower direct buying power but strong users and influencers of future platform adoption | Useful for awareness, trial adoption, training, publications, and long-term pipeline building |
| Research funding, nonprofit, and policy-linked science stakeholders | Foundations, grant bodies, public research agencies, nonprofit research organizations | Indirect influence through grants, partnerships, research program themes, and institutional priorities | Relevant for partnership building, research consortia, and funded pilot programs |
| Scientific technology providers and solution partners | Lab equipment suppliers, genomics tool vendors, scientific software providers, instrumentation companies | Potential exhibitors, sponsors, collaborators, or channel partners rather than pure buyers | Important for partnership, co-marketing, integration, and ecosystem development |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Virtual host location | Online / remote access | Distributed globally | Official website states “Virtual Conference,” removing in-person geographic constraints |
| North America | Likely strong participation from university, biotech, and medical research hubs | High | Likely attendee profile based on bioscience topic mix and virtual accessibility |
| Europe | Likely participation from academic and interdisciplinary life science institutions | High | Strong fit for genomics, computational biology, and translational research communities |
| Asia-Pacific | Likely participation from fast-growing bioscience and biotech ecosystems | Medium to High | Virtual format supports cross-time-zone attendance despite scheduling friction |
| Latin America | Likely research and university participation | Medium | Virtual access may expand reach beyond travel-limited delegates |
| Middle East & Africa | Likely selective participation from academic, hospital, and public research communities | Medium | Reach is enabled by virtual format but not quantified by the organizer |
| International research corridors | Cross-border academic, biotech, omics, and AI-biology networks | High | Especially relevant for collaborations in genomics, synthetic biology, computational biology, and RNA therapeutics |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official website describes MIBIO 2026 as a “premier global forum,” and the event is fully virtual, enabling international participation. |
| National / Regional | Secondary relevance only | Country-specific concentration cannot be confirmed from the provided official source. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| No official current-year attendee list, buyer directory, sponsor roster, exhibitor list, or speaker organization list was identified in the provided official source. To avoid unsupported claims, no speculative buyer company names are inserted here. This limits the event’s usefulness for confirmed attendee-list building, but the event remains relevant for bioscience prospecting by role, institution type, and research focus area. | |||||
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Principal Investigator | Research | Director / Senior Individual Contributor | High scientific influence over lab methods, platforms, collaborations, and vendor evaluation |
| 2 | Research Director | R&D | Director | Relevant for program-level decisions, technology assessment, and external partnerships |
| 3 | Professor / Department Head | Academic Affairs / Research | Director / VP | Can influence institutional adoption, partnerships, and funded research direction |
| 4 | Bioinformatics Director | Bioinformatics / Data Science | Director | Important for omics pipelines, AI-enabled analysis, and scientific software purchasing |
| 5 | Computational Biology Lead | Research / Data Science | Manager / Director | Key role for ML models, simulation tools, and biological data platforms |
| 6 | Laboratory Director | Laboratory Operations | Director | Relevant for instrument, workflow, and lab automation decisions |
| 7 | R&D Manager | Research & Development | Manager | Strong target within biotech and scientific product development teams |
| 8 | Clinical Research Director | Clinical Research | Director | Useful for translational science, molecular research tools, and biomarker support offerings |
| 9 | Scientific Program Manager | Research Programs | Manager | Coordinates projects, external vendors, and collaborative research activities |
| 10 | Procurement Manager, Scientific Supplies | Procurement / Operations | Manager | Relevant in institutions where research teams influence and procurement executes purchases |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Research | Core fit for multidisciplinary bioscience institutions and labs | Research collaboration, scientific software, data platforms, lab technology |
| 2 | Biotechnology | Matches genomics, CRISPR, synthetic biology, and therapeutic innovation themes | R&D platforms, discovery services, translational partnerships |
| 3 | Pharmaceuticals | Relevant for RNA therapeutics, discovery biology, and omics-driven drug development | Drug discovery tools, data workflows, translational science |
| 4 | Higher Education | Academic research is a primary attendee segment | Faculty outreach, institutional licenses, campus research labs |
| 5 | Hospital & Health Care | Relevant through physician and clinical research participation | Clinical research support, translational biology tools, biomarker analysis |
| 6 | Medical Devices | Relevant for biosensors, bioinstrumentation, and advanced imaging themes | Scientific instrumentation and translational device partnerships |
| 7 | Information Technology & Services | Strong fit for computational biology, data infrastructure, and virtual scientific workflows | Cloud infrastructure, scientific data management, integrations |
| 8 | Computer Software | Relevant for bioinformatics, AI models, simulation, and computational research platforms | Analytics, ML tooling, omics workflow software |
| 9 | Nanotechnology | Can intersect with biosensors, delivery systems, and advanced biological engineering | Cross-disciplinary research targeting |
| 10 | Environmental Services | Relevant via microbiome science, sustainability, and green biomanufacturing themes | Bio-based sustainability solutions and environmental bioscience programs |
| 11 | Government Administration | Relevant for public research institutions and grant-linked science programs | Research funding partnerships and public science outreach |
| 12 | Industrial Automation | Fits autonomous labs, high-throughput experimentation, and biofoundries | Automation systems, robotic workflows, lab orchestration |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | Official website review | No participant volume disclosed in the provided official source |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Official website review | No exhibitor directory identified |
| Buyer count | Not publicly confirmed | Unconfirmed | Official website review | No buyer program or attendee segmentation numbers disclosed |
| Speaker count | Not publicly confirmed | Unconfirmed | Official website review | Program committee and accepted papers links exist, but no count was provided in the supplied source text |
| Sponsor count | Not publicly confirmed | Unconfirmed | Official website review | No sponsor list identified in the supplied website content |
| Historical attendance | Not available in the provided official source | Historical data unavailable | Official website review | No prior-year attendance benchmark disclosed |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Genomics and precision biology | Tools for genome analysis, editing workflows, and multiomics integration | Scientific demos, workflow optimization, co-authored pilot studies | Sequencing software, analysis platforms, CRISPR support tools, reagents |
| Computational biology and AI-native biology | Scalable analytics, ML models, simulation environments, biological foundation models | Technical workshops, data integration sessions, platform trials | Bioinformatics software, cloud platforms, AI tooling, data infrastructure |
| Synthetic biology and biomanufacturing | Automation, gene circuit tools, biofoundry workflows, scalable process support | Partnership outreach with R&D and engineering leads | Automation systems, engineering platforms, bioprocess tools |
| RNA biology and therapeutics | Analytical methods, delivery technologies, discovery support, assay development | Scientific consultations and translational collaboration discussions | RNA analytics, therapeutic development support, lab services |
| Advanced imaging and structural biology | Imaging workflows, data handling, high-resolution analysis, instrument support | Application-specific demos and case-study outreach | Imaging software, storage, analysis tools, instrumentation |
| Microbiome, microbiology, and infectious disease biology | Data analysis, assay workflows, translational collaboration, sample processing tools | Research partnership and technology validation outreach | Microbiome analytics, sequencing support, infection biology tools |
| Autonomous labs and self-driving experimentation | Workflow orchestration, robotics, automation, experimental optimization | High-value engagement with lab directors and automation leads | Industrial automation, lab robotics, orchestration software |
| Green biomanufacturing and bio-based sustainability | Sustainable process design, bio-based production methods, environmental bioscience solutions | Programmatic partnership and innovation showcase outreach | Sustainability technologies, process optimization, environmental bioscience services |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Strong fit for scientific, research, biotech, bioinformatics, and lab technology suppliers |
| Decision-maker availability | Medium | Likely presence of senior researchers and department leaders, but no official attendee or speaker org list was confirmed in the provided source |
| Data collection potential | Low | No public buyer directory, sponsor list, or exhibitor roster identified from the supplied official content |
| Apollo targeting potential | High | Topic-based and role-based targeting is strong across research, biotech, pharma, universities, and health research organizations |
| Geographic targeting potential | High | Virtual format supports global campaign design, especially across North America, Europe, and Asia-Pacific research clusters |
| Best outreach approach | High | Use research-theme messaging tied to genomics, AI biology, multiomics, automation, and translational science rather than generic sales outreach |
| Overall lead quality | Medium to High | High topical relevance, but limited confirmed attendee visibility reduces certainty for event-specific list sales |
| Best use case | High | Best for niche bioscience demand generation, role-based outbound targeting, and scientific partnership prospecting |
| Limitations / risks | Medium | Not ideal for confirmed attendee-list building because participation data is not publicly disclosed in the provided source |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Research; Biotechnology; Pharmaceuticals; Higher Education; Hospital & Health Care; Medical Devices; Information Technology & Services; Computer Software; Government Administration; Industrial Automation | Aligns targeting to bioscience research, translational medicine, and scientific technology adoption |
| Departments | Research; Engineering; Information Technology; Operations; Education; Product Management; Clinical; Procurement | Captures both scientific decision-makers and operational buyers |
| Seniority | Director; VP; C-Level; Head; Manager; Owner; Partner; Senior | Focuses on budget holders, technical approvers, and partnership leaders |
| Job titles | Principal Investigator; Research Director; Professor; Department Head; Bioinformatics Director; Computational Biology Lead; Laboratory Director; R&D Manager; Clinical Research Director; Scientific Program Manager; Genomics Director; Head of Research | Targets the most relevant bioscience buying and influence roles |
| Geography | North America; Europe; Asia-Pacific | Most efficient regions for global virtual bioscience event targeting |
| Employee size | 11–50; 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Covers startups, university centers, midsize biotech firms, and enterprise research organizations |
| Keywords | genomics, CRISPR, multiomics, proteomics, microbiome, synthetic biology, RNA therapeutics, bioinformatics, computational biology, AI biology, lab automation, biomanufacturing, structural biology, single-cell, spatial biology | Sharpens topical relevance to the official conference scope |
| Technologies, if relevant | Cloud computing, machine learning, data platforms, sequencing analysis, laboratory automation | Useful for technology-enabled bioscience offerings |
| Revenue range, if relevant | $1M–$10M; $10M–$50M; $50M–$250M; $250M+ | Helps separate venture-stage biotech from mature commercial organizations |
| Company type | Private company; Public company; Educational institution; Nonprofit; Government organization | Reflects the likely institution mix for a research-centered event |
| Funding / public company filters, if relevant | Recently funded biotech; publicly listed life science companies; grant-active research institutions | Supports prioritization by budget readiness and growth activity |
Suggested Apollo Search Logic: ("genomics" OR "bioinformatics" OR "computational biology" OR "synthetic biology" OR "RNA therapeutics" OR "multiomics" OR "CRISPR" OR "microbiome" OR "lab automation" OR "biomanufacturing") AND ("Research Director" OR "Principal Investigator" OR "Bioinformatics Director" OR "Laboratory Director" OR "Head of Research" OR "R&D Manager" OR "Professor") within Research, Biotechnology, Pharmaceuticals, Higher Education, Hospital & Health Care, and Computer Software organizations.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| MIBIO 2026 Official Website | Official event website | Event name, official dates, virtual venue, conference scope, participant profile language, topic areas, and global positioning | High |
| Official website branding / navigation review | Official site review | Program Committee, Accepted Papers, and Contact links exist; however, attendee counts, exhibitor lists, sponsor rosters, and buyer directories were not visible in the provided source text | High for absence confirmation within supplied source; limited for broader web verification |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 5th International Conference of Multidisciplinary & Interdisciplinary Bioscience (MIBIO 2026) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds